RE: Looking poised26 Nov 2025 21:35
Well, we were lead to believe that Q4 would be very busy in terms of newsflow. To date we've had a subsidised placing, the issue of equity in lieu of fees owed, a Corporate Structure Update, Disposal of Non-Core Subsidiary and a new appointment of a Non Executive Director. Probably explains why the SP has dropped from 0.38p to 0.25p in this Quarter. We need news on how the discussions are progressing with the 4 Pharma companies to change the direction of the SP....